{"DataElement":{"publicId":"2431767","version":"1","preferredName":"Invasive Prostate Carcinoma Neoplasm Histologic Type Name","preferredDefinition":"The diagnostic subclassification of an invasive prostate carcinoma.","longName":"2431457v1.0:2433695v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2431457","version":"1","preferredName":"Invasive Prostate Carcinoma Neoplasm by Morphology Name","preferredDefinition":"definition pending:definition pending_The words or language units by which a thing is known.","longName":"2431293v1.0:2222841v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2431293","version":"1","preferredName":"Invasive Prostate Carcinoma Neoplasm by Morphology","preferredDefinition":"definition pending:definition pending","longName":"C48596:C4741","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive Prostate Carcinoma","conceptCode":"C48596","definition":"A carcinoma that is not confined to the prostatic epithelium but has spread to the surrounding stroma of the prostate gland.  The vast majority of invasive prostate carcinomas are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm by Morphology","conceptCode":"C4741","definition":"A classification system grouping neoplasms according to their cellular characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCF450-02CB-3BBF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222841","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6211245-8062-4DD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DE1C74-4ACB-4A9A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Permission to Release DEC granted by primary curator in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2433695","version":"1","preferredName":"Invasive Prostate Carcinoma Neoplasm Histologic Type Name NCI Concept Code","preferredDefinition":"The name of the histologic type._A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"2433695v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Prostatic Duct Adenocarcinoma","valueDescription":"Prostate Ductal Adenocarcinoma","ValueMeaning":{"publicId":"2577131","version":"1","preferredName":"Prostate Ductal Adenocarcinoma","longName":"2577131","preferredDefinition":"A usually aggressive invasive adenocarcinoma of the prostate gland composed of large glands containing tall columnar cells.  The columnar cells have abundant cytoplasm and are reminiscent of endometrial carcinoma.  This type of adenocarcinoma has a tendency to metastasize to the lung and penis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Ductal Adenocarcinoma","conceptCode":"C6813","definition":"A usually aggressive invasive adenocarcinoma of the prostate gland composed of large glands containing tall columnar cells.  The columnar cells have abundant cytoplasm and are reminiscent of endometrial carcinoma.  This type of adenocarcinoma has a tendency to metastasize to the lung and penis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA58-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4C1-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Mucinous Adenocarcinoma","valueDescription":"Acinar Prostate Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"2577198","version":"1","preferredName":"Acinar Prostate Mucinous Adenocarcinoma","longName":"2577198","preferredDefinition":"A usually aggressive morphologic variant of acinar adenocarcinoma of the prostate gland characterized by the presence of lakes of extracellular mucin. This diagnosis applies when at least 25% of the resected tumor contains extracellular mucin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Acinar Mucinous Adenocarcinoma","conceptCode":"C5537","definition":"Acinar adenocarcinoma of the prostate gland characterized by the presence of lakes of extracellular mucin. This diagnosis applies when at least 25% of the resected tumor contains extracellular mucin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA9B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4C4-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Adenocarcinoma NOS","valueDescription":"Prostate Adenocarcinoma ","ValueMeaning":{"publicId":"2581233","version":"1","preferredName":"Prostate Adenocarcinoma ","longName":"2581233","preferredDefinition":"Prostate adenocarcinoma is one of the most common malignant tumors afflicting men. The majority of adenocarcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland. Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival. Several grading systems have been proposed, of which the Gleason system is the most commonly used. Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease. Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma. Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy. Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease. --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Adenocarcinoma","conceptCode":"C2919","definition":"An adenocarcinoma arising from the prostate gland.  It is one of the most common malignant tumors afflicting men.  The majority of adenocarcinomas arise in the peripheral zone and a minority occurs in the central or the transitional zone of the prostate gland.  Grading of prostatic adenocarcinoma predicts disease progression and correlates with survival.  Several grading systems have been proposed, of which the Gleason system is the most commonly used.  Gleason sums of 2 to 4 represent well-differentiated disease, 5 to 7 moderately differentiated disease and 8 to 10 poorly differentiated disease.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic adenocarcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A5E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4AF-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Sarcomatoid Carcinoma","valueDescription":"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant","ValueMeaning":{"publicId":"2577196","version":"1","preferredName":"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant","longName":"2577196","preferredDefinition":"A rare morphologic variant of acinar adenocarcinoma of the prostate gland with unfavorable prognosis, composed of both malignant glandular and sarcomatous components. The sarcomatous component contains a malignant spindle cell proliferation or specific mesenchymal elements including osteosarcoma, chondrosarcoma, and leiomyosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Acinar Sarcomatoid Carcinoma","conceptCode":"C5530","definition":"A rare acinar adenocarcinoma of the prostate gland with unfavorable prognosis. It is composed of both malignant glandular and sarcomatous components. The sarcomatous component contains a malignant spindle cell proliferation or specific mesenchymal elements including osteosarcoma, chondrosarcoma, and leiomyosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA99-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4B2-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Small Cell Carcinoma","valueDescription":"Prostate Small Cell Carcinoma","ValueMeaning":{"publicId":"2581148","version":"1","preferredName":"Prostate Small Cell Carcinoma","longName":"2581148","preferredDefinition":"A neuroendocrine carcinoma of the prostate gland with unfavorable prognosis. It is composed of small cells containing neurosecretory granules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Small Cell Neuroendocrine Carcinoma","conceptCode":"C6766","definition":"A rare small cell neuroendocrine carcinoma that arises from the prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A09-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4B5-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Adenosquamous Carcinoma","valueDescription":"Prostate Adenosquamous Carcinoma","ValueMeaning":{"publicId":"2577129","version":"1","preferredName":"Prostate Adenosquamous Carcinoma","longName":"2577129","preferredDefinition":"An infrequent invasive carcinoma of the prostate gland characterized by the presence of both glandular and squamous neoplastic components. It is more often located in the transitional zone of the prostate gland and it tends to rapidly metastasize to the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Adenosquamous Carcinoma","conceptCode":"C5538","definition":"An infrequent invasive carcinoma of the prostate gland characterized by the presence of both glandular and squamous neoplastic components.  It is more often located in the transitional zone of the prostate gland and it tends to rapidly metastasize to the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA56-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4B8-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Undifferentiated Carcinoma NOS","valueDescription":"Undifferentiated Prostate Carcinoma","ValueMeaning":{"publicId":"2577197","version":"1","preferredName":"Undifferentiated Prostate Carcinoma","longName":"2577197","preferredDefinition":"An invasive prostate carcinoma without evidence of cellular differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Undifferentiated Carcinoma","conceptCode":"C5597","definition":"An invasive prostate carcinoma characterized by the presence of undifferentiated malignant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA9A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4BB-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"},{"value":"Signet-ring Cell Carcinoma","valueDescription":" Acinar Prostate Adenocarcinoma, Signet Ring Variant  ","ValueMeaning":{"publicId":"2577130","version":"1","preferredName":" Acinar Prostate Adenocarcinoma, Signet Ring Variant  ","longName":"2577130","preferredDefinition":"A morphologic variant of acinar adenocarcinoma of the prostate gland characterized by the presence of signet ring malignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Acinar Signet Ring Cell-Like Adenocarcinoma","conceptCode":"C5535","definition":"Acinar adenocarcinoma of the prostate gland characterized by the presence of malignant cells with intracytoplasmic vacuoles that displace the nucleus to the periphery of the cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA57-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2006-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"06459C26-C4BE-6BA7-E044-0003BA3F9857","beginDate":null,"endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"ONEDATA","dateModified":"2005-11-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2183782","version":"1","preferredName":"NCIP","preferredDefinition":"Cancer Biomedical Informatics Grid","longName":"NCIP","context":"NCIP","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DACB2549-3BE3-73F7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433292","version":"1","preferredName":"NCI Concept Code","preferredDefinition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","longName":"C43516","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NCI Concept Code","conceptCode":"C43516","definition":"A concept unique identifier within the NCI Enterprise Vocabulary Service's NCI Thesaurus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"062A6784-EC8C-6CFB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"CROWLEYR","dateCreated":"2005-11-22","modifiedBy":"ONEDATA","dateModified":"2005-11-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06459C26-C233-6BA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"CURTIST","dateModified":"2010-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2534075","version":"1.2","longName":"caTISSUE CAE","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812224","version":"1","longName":"edu.pitt.cabig.cae.domain.prostate","context":"NCIP"}]}],"AlternateNames":[{"name":"edu.upmc.opi.cabig.caties.cap.domain.prostate.InvasiveProstateCarcinomaNeoplasmHistologicType.name","type":"UML Qualified Attr","context":"NCIP"},{"name":"InvasiveProstateCarcinomaNeoplasmHistologicType:name","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"NCIP"}],"origin":"CAP PROTOCOLS:College of American Pathologists Cancer Protocols","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DDC3EB-B77B-74E3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-09","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"REEVESD","dateModified":"2009-07-16","changeDescription":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}